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Abstract 
Background: Rheumatoid arthritis (RA) is a chronic multisystemic disease which can lead to significant 
deformities and functional disability.Objectives:is to estimate level of salivary Leptin, flow rate and pH of saliva 
among group of patients with rheumatoid arthritis according to treatment.Patients and methods: Study design ;a 
case control study included Fifty women patients with rheumatoid arthritis; twenty-five on Methotrexate 
treatment and twenty-five on combination treatment of Methotrexate and Etanercept selected as study groups 
with an age range (30-40) years old and twenty-five gender, age and Body Mass Index matched healthy looking 
persons were selected as control. Collection of unstimulated salivary samples was carried out under standard 
conditions then salivary flow rate, pH in addition salivary Leptin was estimatedResults after adjustment for age, 
gender and body mass index; mean salivary flow rate was highest among rheumatoid arthritis cases on 
combination treatment (Etanercept and Methotrexate) =0.4±0.202 ml/min and least significant difference test 
between groups was statistically significant (p< 0.05). The mean salivary pH was highest among rheumatoid 
arthritis cases on combination treatment (Etanercept and Methotrexate) =7.1±0.29; however the differences 
between groups failed to reach the level of statistical significance. The median of salivary Leptin was highest 
among rheumatoid arthritis cases on Methotrexate =0.65ng/ml without statistically significant difference 
between groups, furthermore the salivary levels of Leptin in this study reveals weak correlation with disease 
activity score 28 r=0.127/p=0.42 among rheumatoid arthritis patients.  Conclusions:the whole unstimulated 
salivary flow rate was higher among rheumatoid arthritis cases on combination treatment (Etanercept and 
Methotrexate) revealing improvements in salivary gland functions, the study also concluded that salivary Leptin 
level is of low importance to assess disease activity to rheumatoid arthritis patients .  
Keywords: rheumatoid arthritis, salivary flow rate, salivary Leptin 
 
Introduction ; Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that affects all ethnic 
groups throughout the world (1, 2). The extra-articular organ involvements include the skin, eye, heart, and lung, 
renal, nervous and gastrointestinal systems    (7, 8). oral dryness and salivary gland swelling also in patients with 
RA. These patients can also develop secondary Sjögren's syndrome which is relatively common in 6 to 10% of 
patients(8 and 22). The normal unstimulated salivary flow rate ranges from 0.25 to 0.35 mL/min, low ranges from 
0.1 to 0.25 mL/min, while hypo salivation is characterized by a salivary flow rate of less than 0.1 mL/min (9). The 
main factors responsible for a decreased flow rate are therapeutic drugs and radiation treatment for cancer (10). 
Hyposalivation is attributed to destruction of the gland and dysfunction on the residual glandular tissue (11).   
Dryness of the mouth causes discomfort and a stinging sensation with difficulty in chewing and swallowing dry 
food, resulting in increase in gingival disease, dental caries and difficulty in wearing dentures (12, 13, and 14). Hadi et 
al. (15) found that Xerostomia was the most prominent oral manifestations of RA among study group of Iraqi 
rheumatoid arthritis patients. Leptin is a peptide hormone that initially thought to regulate body weight by 
inhibiting food intake and by stimulating energy expenditure (16); it also seems to play a role in autoimmune 
diseases such as RA (7). In RA, circulating leptin levels have been described as either higher or unmodified in 
comparison to healthy controls; and leptin may be directly implicated in the pathogenesis of RA. but, results of 
other studies assessing leptin concentrations in patients with RA have been controversial (17). Saliva is a body 
fluid that contain biomarkers within its components making it an attractive diagnostic tool that could be used as 
an alternative to blood in tests measuring biomarkers. 
 
2. Patients and Methods 
2.1 Study design 
A case–control study was conducted in the outpatient consultation clinic of rheumatology Unit in Baghdad 
Teaching Hospital during the period between December 2012 and May 2013. Patients with RA, diagnosed on 
base of American College of Rheumatology Criteria for the classification of RA [10].This study was granted full 
ethical approval from the local ethics committee and all the patients have given informed written consents prior 
to the commencement of our study. 
Patients were excluded from the study if there were evidences ofoverlapping connective tissue disease, 
or pregnancy. 
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2.2 Clinical, laboratory, and radiological evaluation 
Patients data were obtained via face-to face interview with the researcher. Focused history was taken including: 
age, sex, duration of RA ,smoking , patients self-assessment of disease activity or Visual Analogue Scale for the 
patient (Patient s VAS), functional status was assessed according to the criteria for classification of functional 
status in rheumatoid arthritis [11] and drug related history (corticosteroids, disease modifying antirheumatoid 
drugs (DMARDS),and biologic agents). 
Each patient was examined for detecting tender and swollen joints, rheumatoid nodules, hand 
deformities,and mouth examination . 
A blood sample was taken for the measurement of Erythrocyte sedimentation rate (ESR) wasmeasured 
(usingWestergren’s method, in mm/ hour) and rheumatoid factor (using latex fixation test) . 
Disease activity was assessed according to Disease Activity Score for 28 joints (DAS 28). DAS28 was 
calculated from the number of tender and swollen joints (28-joint count), patient s self-assessment of disease 
activity 
(VAS) , and ESR according to the following formula [12]: 
DAS28 = (0.56 * tender joint count 1/2) + (0.28 * swollen joint count 1/2) + (0.7 * ln [ESR]) + 
(0.014*VAS). 
X-rays of both hands in postero-anterior view (PA view) were obtained ,and the progression of 
rheumatoid arthritis patients was classified according to steinbrocker classification [13]. study and control 
groups were examined gathering a total sum of seventy five women with an age range (30 to 40) years old; fifty 
of them were (study group) were diagnosed as established RA patients. RA patients were divided into two 
subdivisions groups: the first group (twenty five) under conventional treatment disease-modifying antirheumatic 
drugs DMARD (Methotrexate MTX) and the second group (twenty five) under combination treatment with anti-
TNF-α (Etanercept) and DMARDs (MTX). 
The control group composed of twenty five subjects and they were apparently healthy according to 
their medical history matching with age, gender and body mass index BMI of the study group. The body mass 
index (BMI) was calculated as (body weight/height 2) (kg/m2). 
Unstimulated saliva collected after subjects instructed to relax and to swallow all saliva present in their 
mouths; while seated and leaning forward, they were told to spit all the saliva they produce into a graduated 
sterile labeled screw capped bottle test tube. The un stimulated whole saliva collected for 5 minutes was then 
measured by volume and expressed as milliliters per minute (ml/min). Each salivary sample was separated in 
two parts, one for the measurements of pH of saliva by using an electronic pH meter, and other part was 
centrifuged at 3000 r.p.m for 10 minutes then the clear supernatants was separated by micropipette and then 
stored at (-200C) in a deep freeze till the time of biochemical analysis. To obtain the most critical consistency of 
diagnostic criteria inter and intra examiner calibrations were performed. 
 
2.3 Statistical analysis 
Data of  recruited patients in this study were checked for any errors or inconsistencies and transferred into 
computerized database software with analytic facilities; Statistical package for social sciences (SPSS) was used 
in all statistical analysis and procedures. Statistical analysis data were translated into a computerized database 
structure. The database was examined for errors using range and logical data cleaning methods, and 
inconsistencies were remedied. Compliance of quantitative random variables with Gaussian curve (normal 
distribution) was analyzed using the Kolmogorov-Smirnov test. Age, BMI, flow rate of saliva and pH where 
shown to be normally distributed quantitative continuous outcome variables and described by mean, SD 
(standard deviation) and SE (standard error). The statistical significance of difference in mean between 2 groups 
was assessed using the independent samples t-test, while between more than 2 groups ANOVA test was used. 
When ANOVA model shows a statistically significant difference, further exploration of the statistical 
significance of difference in mean between each pair of groups was assessed by LSD (least significant 
difference). Salivary Leptin was non-normally distributed quantitative variables. Such variable can be described 
by median, which is not sensitive for differences in group average. In such a condition the mean rank is useful in 
comparing the central tendency (group center) of compared groups. The difference in mean rank between 2 
groups was assessed by non-parametric test (Mann-Whitney), while between 3 groups Kruskal-Wallis test was 
used. An expert statistical advice was sought for. Statistical analyses were done using SPSS version 20 computer 
software (Statistical Package for Social Sciences).  
The correlation coefficient tests between the variables were done by using Spearman’s rank linear 
correlation coefficient. P value less than 0.05 and 0.01 was considered statistically significant. 
 
3. Results 
Age and body structure represented in Table1, in which study and control groups were comparable. 
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Table 1: Age and Body Mass Index among Study Groups. 
Age in years 
 
 
Range 
Mean 
SD 
BMI (Kg/m2) 
Range 
Mean 
SD 
Apparently 
healthy controls 
n=25 
(30-40) 
33.8 
3.2 
(18.3-38.6) 
28.4 
5.66 
Rheumatoid arthritis 
treated with Methotrexate 
n=25 
(30-40) 
34.1 
3.78 
(16.9-44.4) 
30.1 
7.7 
Rheumatoid arthritis 
treated with 
Etanercept 
n=25 
(30-40) 
35.8 
3.57 
(17.3-45) 
28.5 
5.73 
P value 
(NS) 
(NS) 
* d.f (between groups/within groups) = 2/72.  
SD standard deviation 
NS non significant 
BMI Body Mass Index 
Kg kilogram 
m2square meter 
 
Body Mass Index of study groups ranged from (16.9 to 45) Kg/m2 with a mean of (28.4 to 30.1) Kg/m2 with no 
statistically significant difference between three groups. The mean salivary flow rate was highest among RA 
cases on Etanercept treatment (0.4 ml/min) and lowest in RA cases on MTX (0.26 ml/min). The difference 
observed in mean salivary flow rate between three groups was statistically significant. The mean salivary flow 
rate was significantly lower (0.26 ml/min) in RA on MTX compared to both RA on Etanercept and controls (0.4 
ml/min and 0.36 ml/min respectively). There was no statistically significant difference in mean salivary flow rate 
between RA cases on Etanercept and controls (Table 2). 
Table 2: Comparison of mean salivary flow rate among three groups (Control, RA on MTX and RA on 
Etanercept). 
Variabl
e 
Salivar
y flow 
rate 
Control 
group 
(mean 
±SD) 
N=25 
0.36±0.13
4 
Methorexat
e 
group 
(mean ±SD) 
N=25 
0.26±0.117 
Etanercep
t 
group 
(mean 
±SD) 
N=25 
0.4±0.202 
P1 
Control 
+ 
Methotrxat
e 
0.024 
P2 
Control 
+ 
Etanercep
t 
0.37(NS) 
P3 
Methotrxat
e 
+ 
Etanercept 
0.002 
F 
value 
5.47
4 
P 
Value for 
Differenc
e 
Between 
3 groups 
0.006 
* d.f (between groups/within groups) = 2/72.  
SD standard deviation 
RA rheumatoid arthritis 
MTX methotrexate 
 
Regarding salivary pH; its mean was obviously highest among RA cases on Etanercept (pH =7.1) followed by 
control group (pH =7) and lowest among RA cases on MTX   (pH =6.9).  The differences observed however, 
failed to reach the level of statistical significance (Table 3).                                                                                
Table 3: Comparison of mean salivary pH among three groups (Control, RA on MTX and RA on 
Etanercept). 
Variable 
Salivary 
pH 
Control 
group 
(mean 
±SD) 
N=25 
7±0.2 
Methorexate 
group 
(mean ±SD) 
N=25 
6.9±0.34 
Etanercept 
group 
(mean 
±SD) 
N=25 
7.1±0.29 
P1 
Control 
+ 
Methotrxate 
** 
P2 
Control 
+ 
Etanercept 
** 
P3 
Methotrxate 
+ 
Etanercept 
** 
F 
value 
(NS) 
P 
Value for 
Difference 
Between 
3 groups 
(NS) 
* d.f (between groups/within groups) = 2/72. 
** Not calculated, because the overall P values for difference between three groups didn’t reach the level of 
statically significance.  
N number 
NS non significant 
The median salivary Leptin was obviously highest among RA cases on MTX (0.65ng/ml). The median of 
salivary Leptin among RA cases on Etanercept and controls were (0.42ng/ml and0.42ng/ml respectively) (Table 
4).  
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Table 4: The difference in: median and mean rank of salivary Leptin between two RA cases groups and 
control. 
Salivary CRP (mg/1) 
Range 
Median 
Mean Rank 
Inter-quartile range 
Apparently 
 healthy controls N=25 
(0.42-1.8) 
0.42 
36.7 
(0.42-0.65) 
RA treated with 
Methotrexate 
 N=25 
(0.42-2.04) 
0.65 
43.9 
(0.42-0.88) 
RA treated Etanercept  
N=25 
(0.42-2.62) 
0.42 
33.4 
(0.42-0.65) 
P value 
(NS) 
CRP c-reactive protein 
    N number 
   NS non significant 
   RA Rheumatoid arthritis 
mg/1 milligram/milliliter 
 
The differences observed however, failed to reach the level of statistical significance. there was statistically non 
significant difference between high and low of disease activity in salivary flow rate and salivary pH(Table 5).   
Table 5: Comparison of mean salivary flow rate, salivary pH and plaque index among RA cases with high 
disease activity (DAS=5.1) and those with low disease activity. 
High disease activity (DAS=5.1+) 
Salivary variables 
Salivary Flow rate 
(ml/min) 
pH 
Low activity  
(mean ±SD) 
N=23 
0.34 ± 0.177 
7.00 ± 0.2 
High activity 
(mean ±SD) 
N=20 
0.32 ± 0.207 
7.00 ± 0.34 
P Value between 
two groups 
 (NS) 
 (NS) 
* d.f = 41.  
DAS disease activity score 
N number 
SD standard deviation 
RA Rheumatoid arthritis 
 
There was statistically not significant difference between positive and negative of high disease activity in 
salivary Leptin. (Table 6) 
Table 6: The difference in median and mean rank salivary biomarkers between RA cases with high disease 
activity (DAS=5.1) and those with low disease activity. 
High disease activity (DAS=5.1+) 
 
Salivary biomarkers 
Salivary Leptin (ng/ml) 
Low activity 
Median (Mean rank). 
     N=23 
0.42 (21.3) 
High activity 
Median (Mean rank). 
     N=20 
0.42 (22.8) 
P 
Value 
NS 
* d.f = 41. 
DAS disease activity score 
N number 
Ng nanogram 
NS non significant 
 
4. Discussion 
Rheumatoid arthritis (RA) is a chronic systemic, inflammatory disease affecting the adult population. Affected 
individuals experience significant morbidity, including loss of function, joint destruction, and permanent 
deformity, and have higher mortality than the general population (18). This study enrolled 50 patients and 25 
apparently healthy subjects, to estimate salivary biomarkers (Leptin) with evaluation of some salivary 
parameters (salivary flow rate and salivary pH) In relation to the activity of the disease, the group of rheumatoid 
arthritis patients subdivided according to treatment type into conventional treatment Methotrxate (MTX) and 
new combination treatment (anti-TNF-α (Etanercept) and MTX) subgroups. Through modulating the ecosystem 
within the oral cavity. Alterations, quantitatively and/or qualitatively in salivary secretions may lead to 
deleterious effect on many aspects of oral function and general wellbeing (19, 20). In this study unstimulated 
salivary flow rate was measured for RA cases; patients on MTX and patients who received Etanercept, in 
addition to the control subjects for comparison; the study of unstimulated salivary secretion is an accurate 
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method to analyze salivary gland status (19).The salivary flow rate was found to be significantly lower among RA 
cases on MTX (0.26 ml/min) in comparison to both RA on Etanercept and controls (0.4 ml/min and 0.36 ml/min 
respectively). This decreasing of salivary function in RA is assumed to be related to the lymphocytic infiltrate of  
affected glands resulting in decrease salivation and chemical changes, Methotrxate is among chemotherapies 
agents that reduced salivary flow rate (21). Decrease salivary flow rate among RA cases also were obtained by 
Hadi et al. 2011and Zalewska et al., 2011(15, 20), revealing similarities with results of present study, although Hadi 
et al. 2011 recorded higher mean salivary flow rate for study and control groups  which may be attributed to 
variation in age, gender BMI, fasting condition, duration of disease and duration of treatment. The unstimulated 
flow rate averages 0.25 to 0.35ml per minute (23). Etanercept group in present study reported mean salivary flow 
rate to be near mean of that among controls. Etanercept is one of several TNF inhibitors approved for rheumatoid 
arthritis (RA) and a variety of other immune-mediated inflammatory conditions (24). Results of present study 
reports an improvement in amount of salivary gland secretion as treatment with Etanercept has proven successful 
in reducing chronic inflammation (25), another explanation for this improvement is effectiveness of Etanercept  in 
blocking TNF-α-mediated apoptosis in salivary gland epithelial cells of Sjögren's syndrome: secondary 
manifestation of RA (26), however results of present study disagree Sankar et al., 2004(27) who found no evidence 
to suggest that treatment with Etanercept was clinically efficacious in Sjögren's syndrome. This may explained 
by short duration time of treatment (12 weeks). The capacity of human saliva to stabilize acids is essential for 
maintaining pH in the oral environment above critical levels (28). The current study revealed an elevation in pH 
among RA cases on Etanercept (pH =7.1) followed by control group (pH =7) and lowest among RA cases on 
MTX   (pH =6.9), however the results don’t reach the significant difference. Corvo et al in 2012(29) found that no 
statistically significant difference in the salivary pH of individuals with secondary Sjögren s syndrome and 
healthy individuals, both in the non-stimulated total saliva as well as in the total stimulated saliva, these findings 
come in agreement with results of current study. In present study the salivary pH among study and control 
groups remain within physiological range pH = 6.0–7.0 (30 and 31) with slightly alkaline pH, these results are not 
contrary to expectations since the physiological salivary pH range increases as the flow rate of saliva increases 
and vice versa (19 and 32) since the pH values come in coordination with salivary flow rates among groups. The 
slight alkaline pH among study groups, can be explain by evidences obtained from other studies; urea was found 
to be higher among patients with chronic periodontal diseases, urea is metabolized quickly by bacterial urease, 
producing ammonia and carbonic gas causing an elevation in the pH of the saliva (33).  
Estimation of levels of salivary Leptin among RA patients were one of aims of current study, Levels of 
salivary Leptin were measured in this study to be obviously higher among RA patients on MTX (median 0.65 
ng/ml) while median of salivary Leptin for both RA on Etanercept and controls (median 0.42 ng/ml), though the 
difference failed to reach the level of statistical significance, also levels of Leptin in this study reveals weak 
correlation with DAS 28 among RA patients (0.127/p=0.42). Findings of current study agree with Hizmetly et al., 
in 2007(34) who demonstrated that there wasn’t any significant difference at plasma Leptin levels between RA 
patients and control group . Other studies reported higher serum leptin level in RA patients in comparison to 
healthy controls (35); the reasons for this discrepancy between results of studies may be related to the effects of 
medications used for treatment or to the differences in body mass indices of patients with RA. Also chronic 
periodontitis affect Leptin concentration in saliva because chronic inflammation induces a suppression of Leptin 
synthesis (36). No study regarding Etanercept (anti-TNF biological treatment) effect on Leptin level among RA 
patients could be found, but Popa et al., 2009(73) found similar Leptin concentrations compared with the controls 
and anti-TNF therapy (Inflaximap) have limited influence on plasma Leptin concentrations.  
 
5. Conclusion 
the whole unstimulated salivary flow rate was found to be higher among rheumatoid arthritis cases on 
combination of treatment (Methotrexate and Etanercept) revealing improvements in salivary gland functions. 
Also salivary Leptin level is of low importance to assess disease activity to rheumatoid arthritis patients. 
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